BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27420920)

  • 1. Minireview: Regulatory T Cells and Ovarian Cancer.
    Singh M; Loftus T; Webb E; Benencia F
    Immunol Invest; 2016 Nov; 45(8):712-720. PubMed ID: 27420920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura.
    Arandi N; Mirshafiey A; Jeddi-Tehrani M; Shaghaghi M; Sadeghi B; Abolhassani H; Sharifian RA; Rahiminejad MS; Aghamohammadi A
    Iran J Allergy Asthma Immunol; 2014 Apr; 13(2):85-92. PubMed ID: 24338252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a FOXP3(+)CD3(+)CD56(+) population with immunosuppressive function in cancer tissues of human hepatocellular carcinoma.
    Li X; Peng J; Pang Y; Yu S; Yu X; Chen P; Wang W; Han W; Zhang J; Yin Y; Zhang Y
    Sci Rep; 2015 Oct; 5():14757. PubMed ID: 26437631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells.
    Wang B; Li B; Dai Z; Ren S; Bai M; Wang Z; Li Z; Lin S; Wang Z; Huang N; Yang P; Liu M; Min W; Ma H
    Int J Biochem Cell Biol; 2014 Oct; 55():98-108. PubMed ID: 25168696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
    Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
    Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells.
    Shuai X; Wei-min L; Tong YL; Dong N; Sheng ZY; Yao YM
    Sci Rep; 2015 Sep; 5():14478. PubMed ID: 26411375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment.
    Govindaraj C; Scalzo-Inguanti K; Madondo M; Hallo J; Flanagan K; Quinn M; Plebanski M
    Clin Immunol; 2013 Oct; 149(1):97-110. PubMed ID: 23948613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer.
    Biller BJ; Elmslie RE; Burnett RC; Avery AC; Dow SW
    Vet Immunol Immunopathol; 2007 Mar; 116(1-2):69-78. PubMed ID: 17224188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
    Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
    Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1.
    Hsu P; Santner-Nanan B; Hu M; Skarratt K; Lee CH; Stormon M; Wong M; Fuller SJ; Nanan R
    J Immunol; 2015 Oct; 195(8):3665-74. PubMed ID: 26363058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy.
    Ravi R; Noonan KA; Pham V; Bedi R; Zhavoronkov A; Ozerov IV; Makarev E; V Artemov A; Wysocki PT; Mehra R; Nimmagadda S; Marchionni L; Sidransky D; Borrello IM; Izumchenko E; Bedi A
    Nat Commun; 2018 Feb; 9(1):741. PubMed ID: 29467463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte-mediated Immune Regulation in Health and Disease: The Treg and γδ T Cell Co-conspiracy.
    Payne KK
    Immunol Invest; 2016 Nov; 45(8):767-775. PubMed ID: 27617588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.
    Zhang S; Ke X; Zeng S; Wu M; Lou J; Wu L; Huang P; Huang L; Wang F; Pan S
    Cell Mol Immunol; 2015 Sep; 12(5):580-91. PubMed ID: 26166762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
    Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
    Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and expression of inhibitory markers of CD4(+) CD25(+) FOXP3(+) regulatory T cells in patients with common variable immunodeficiency.
    Arandi N; Mirshafiey A; Abolhassani H; Jeddi-Tehrani M; Edalat R; Sadeghi B; Shaghaghi M; Aghamohammadi A
    Scand J Immunol; 2013 May; 77(5):405-12. PubMed ID: 23432692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of human regulatory T cells in the setting of T-cell activation and anti-CTLA-4 immunotherapy on the basis of expression of latency-associated peptide.
    Sun J; Tang DN; Fu T; Sharma P
    Cancer Discov; 2012 Feb; 2(2):122-30. PubMed ID: 22585857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atopic dermatitis induces the expansion of thymus-derived regulatory T cells exhibiting a Th2-like phenotype in mice.
    Moosbrugger-Martinz V; Tripp CH; Clausen BE; Schmuth M; Dubrac S
    J Cell Mol Med; 2016 May; 20(5):930-8. PubMed ID: 26931745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.